Woodline Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-144,469
Closed -$2.37M 604
2023
Q2
$2.37M Sell
144,469
-160,853
-53% -$2.62M 0.03% 409
2023
Q1
$5.1M Buy
305,322
+36,154
+13% +$582K 0.07% 293
2022
Q4
$4.15M Buy
+269,168
New +$4.17M 0.06% 344

Other funds holding BMEZ

Woodline Partners's BMEZ Position: Q3 2023 in Review

Woodline Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2023, closing a stake of 144,469 shares — an estimated $2.37M sold.

Woodline Partners first reported a position in BMEZ in Q4 2022 and held it in 3 quarters. The position peaked at $5.1M in Q1 2023. 98 funds tracked by Wall St. Rank hold BMEZ as of Q3 2023.

  • Woodline Partners reported no remaining BlackRock Health Sciences Trust II position as of Q3 2023 after selling out during the quarter.
  • Woodline Partners sold 144,469 BlackRock Health Sciences Trust II shares in Q3 2023, an estimated $2.37M.
  • Woodline Partners first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 3 quarters.
  • Woodline Partners's BlackRock Health Sciences Trust II position peaked at $5.1M in Q1 2023.
  • 98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2023.

Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.